Biochemical evaluation, including serum chromogranin A and 24-hour urinary 5-hydroxyindoleacetic acid (5-HIAA), is recommended to support the suspicion of a neuroendocrine tumor and to monitor disease progression [4]. Here, CHGA is linked to neuroendocrine neoplasm.